Health Condition 1: N181- Chronic kidney disease, stage 1 Health Condition 2: N182- Chronic kidney disease, stage 2 (mild) Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate)
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Fourrts India Laboratories Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adult patients with diabetes mellitus or hypertension maybe diagnosed with chronic kidney disease (CKD) Stage 1, Stage 2 and up to Stage 3. 2. Adult patients with microalbuminuria result ranging from 30-300mg/day.
Exclusion criteria
Exclusion criteria: Patients with incomplete medical records with respect to the required study parameters
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in urinary albumin to creatinine ratio (uACR) from baseline to study endTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in microalbuminuria within treatment time period of 3 months 2.Tolerability evaluated based on adverse events recorded by the treating physician during the treatment period of 3 months 3.Casualty assessment of adverse events recorded by the treating physician, if anyTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Monjori Mitra
Medclin Research Pvt Ltd
Outcome results
None listed